SCHEMBL19002068

SCHEMBL19002068

Cc1[nH]c2ccccc2c(=O)c1-c1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.46
SLC2A1 P11166 1/20 0.45
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAT2A P31153 1/20 0.41
SERPINE1 P05121 1/20 0.41
VDR P11473 1/20 0.41
HTT P42858 3/20 0.41
IMPDH2 P12268 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
GLA P06280 2/20 0.39
GAA P10253 2/20 0.39
PTGS2 P35354 2/20 0.39
CCR6 P51684 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
NR4A2 P43354 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31511941 0.95 KIF11 (0.48) KIF11SLC2A1MAPTKMT2ATDP1
SCHEMBL26924248 0.95 KIF11 (0.48) KIF11SLC2A1MAPTKMT2ATDP1
SCHEMBL22392867 0.87 SLC2A1 (0.51) SLC2A1MAPTHTTIMPDH2ABCG2
SCHEMBL29768834 0.87 SLC2A1 (0.51) SLC2A1MAPTHTTIMPDH2ABCG2
SCHEMBL30925687 0.85 MAT2A (0.56) KIF11SLC2A1KMT2AMAT2AKDM4E
SCHEMBL30925685 0.85 MAT2A (0.56) KIF11SLC2A1KMT2AMAT2AKDM4E
SCHEMBL25658498 0.84 SLC2A1 (0.44) KIF11SLC2A1MAT2AKDM4EPTGS2
SCHEMBL8533470 0.84 MAT2A (0.54) KIF11MAPTKMT2ATDP1MAT2A
SCHEMBL29505903 0.84 MAT2A (0.54) KIF11MAPTKMT2ATDP1MAT2A
SCHEMBL19047285 0.84 KDM4C (0.45) SLC2A1MAT2AIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11414385-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases THE UNIVERSITY OF CHICAGO 2022-08-16 US claimed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US claimed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US claimed
CN-110545815-B Medical application of cytochrome bc1 complex inhibitor 北京蔚蓝之源医药科技有限公司 2024-07-05 CN disclosed
US-20240182421-A1 SYNTHESIS OF ENDOCHIN-LIKE QUINOLONES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-06-06 US disclosed
US-11964944-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases THE UNIVERSITY OF CHICAGO (US) 2024-04-23 US disclosed
EP-4308109-A1 SYNTHESIS OF ENDOCHIN-LIKE QUINOLONES Oregon Health & Science University (US) 2024-01-24 EP disclosed
CN-117042768-A Synthesis of enodoxine-like quinolones 俄勒冈健康与科学大学 2023-11-10 CN disclosed
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites THE UNIVERSITY OF SHEFFIELD (GB) 2023-06-15 US disclosed
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites THE UNIVERSITY OF SHEFFIELD (GB) 2023-06-15 US disclosed
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites THE UNIVERSITY OF SHEFFIELD (GB) 2023-06-15 US disclosed
US-11414385-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases THE UNIVERSITY OF CHICAGO 2022-08-16 US disclosed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US disclosed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US disclosed
US-20200283391-A1 Compounds and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases THE UNIVERSITY OF CHICAGO 2020-09-10 US disclosed
US-20200283391-A1 Compounds and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases THE UNIVERSITY OF CHICAGO 2020-09-10 US disclosed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US disclosed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US disclosed
WO-2017112678-A1 COMPOUNDS AND METHODS FOR TREATING, DETECTING, AND IDENTIFYING COMPOUNDS TO TREAT APICOMPLEXAN PARASITIC DISEASES MCLEOD RIMA (US) 2017-06-29 WO disclosed
WO-2017103615-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283391-A1 Compounds and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases TUBB1, MYADM, TUBB KIF11 3261/4885SLC2A1 4082/4885MAPT 2969/4885
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor NDUFB7, NDUFB3, NDUFB5 KIF11 2588/4885SLC2A1 315/4885MAPT 1315/4885
US-20240182421-A1 SYNTHESIS OF ENDOCHIN-LIKE QUINOLONES ENGASE, ESYT2, VPS4B KIF11 3259/4885SLC2A1 4039/4885MAPT 4104/4885
US-11964944-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases TUBB1, MYADM, TUBB KIF11 3312/4885SLC2A1 4114/4885MAPT 2933/4885
US-11414385-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases TUBB1, MYADM, TUBB KIF11 3261/4885SLC2A1 4082/4885MAPT 2969/4885
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites CYP11B2, CYP11B1, COX5B KIF11 3110/4885SLC2A1 4289/4885MAPT 2636/4885
US-20190151305-A1 COMBINATION PRODUCT NDUFB5, NDUFB7, NDUFB10 KIF11 1969/4885SLC2A1 374/4885MAPT 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.